HIGHBRIDGE CAPITAL MANAGEMENT LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAD3. A total of 7 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2021$15,825,000
-28.3%
15,000,000
-28.3%
0.42%
-31.7%
Q2 2021$22,064,0000.0%20,914,0000.0%0.61%
-30.4%
Q1 2021$22,064,000
-25.0%
20,914,000
-32.6%
0.88%
-21.9%
Q4 2020$29,401,000
+73.7%
31,014,000
+63.1%
1.13%
+23.5%
Q3 2020$16,922,000
+7.9%
19,014,000
+8.5%
0.91%
-31.7%
Q2 2020$15,687,000
+28.1%
17,527,000
+21.7%
1.34%
+1.8%
Q1 2020$12,246,000
-4.4%
14,407,0000.0%1.31%
-7.5%
Q4 2019$12,813,000
-21.9%
14,407,000
-25.8%
1.42%
-40.8%
Q3 2019$16,398,000
-8.5%
19,407,0000.0%2.39%
+101.9%
Q2 2019$17,927,000
+1.7%
19,407,0000.0%1.19%
+118.8%
Q1 2019$17,624,000
+8.3%
19,407,0000.0%0.54%
+12.9%
Q4 2018$16,272,000
-19.1%
19,407,000
-1.3%
0.48%
+0.4%
Q3 2018$20,120,000
+31.7%
19,665,000
+11.3%
0.48%
+55.7%
Q2 2018$15,276,000
+2.9%
17,665,000
+9.3%
0.31%
+27.9%
Q1 2018$14,842,000
-4.5%
16,165,000
+2.5%
0.24%
-13.4%
Q4 2017$15,548,000
+147.2%
15,765,000
+110.2%
0.28%
+194.7%
Q3 2017$6,290,000
-17.2%
7,500,000
+7.1%
0.09%
-16.8%
Q2 2017$7,597,000
-24.5%
7,000,000
-10.9%
0.11%
-22.6%
Q1 2017$10,056,000
-24.0%
7,856,000
-49.5%
0.15%
-37.9%
Q4 2016$13,223,00015,556,0000.24%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 20,914,000$22,064,0000.88%
WHITEBOX ADVISORS LLC 5,000,000$4,857,0000.16%
ANGELO GORDON & CO., L.P. 1,397,000$1,357,0000.12%
UBS OCONNOR LLC 8,000,000$7,840,000,0000.11%
INGALLS & SNYDER LLC 500,000$490,0000.02%
CITIGROUP INC 7,832,000$7,608,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders